156 related articles for article (PubMed ID: 35433954)
1. Evaluating the direct medical cost, drug utilization and expenditure for managing Parkinson's disease: a costing study at a medical center in China.
Yi ZM; Li XY; Wang YB; Wang RL; Ma QC; Zhao RS; Chen LC
Ann Transl Med; 2022 Mar; 10(6):330. PubMed ID: 35433954
[TBL] [Abstract][Full Text] [Related]
2. The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis.
Wang R; Li X; Gu X; Cai Q; Wang Y; Yi ZM; Chen LC
Front Public Health; 2023; 11():1159119. PubMed ID: 37228740
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effectiveness, safety, and costs of anti-Parkinson drugs: A multiple-center retrospective study.
Li W; Zhang H; Zhang Y; Wang K; Hui J; Yi Z
CNS Neurosci Ther; 2024 Apr; 30(4):e14531. PubMed ID: 37983933
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of substitutional effect of outpatient expenditure on inpatient expenditure in hypertensive patients with rural new cooperative medical scheme].
Zhang HY; Jian WY; Fang H
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 48(3):472-7. PubMed ID: 27318910
[TBL] [Abstract][Full Text] [Related]
5. [Trend in medical expenditures for patients with kidney diseases: An analysis from a tertiary hospital in Beijing].
Bi SH; Li ZF; Wang T; Wang Y; Zhang C; Ji H; Shi J
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Nov; 53(1):215-219. PubMed ID: 33550360
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of managing Type 2 diabetes mellitus: Analysis from a Teaching Hospital in Malaysia.
Ismail A; Suddin LS; Sulong S; Ahmed Z; Kamaruddin NA; Sukor N
Indian J Public Health; 2017; 61(4):243-247. PubMed ID: 29219128
[TBL] [Abstract][Full Text] [Related]
7. [Survey of economic burden of hepatitis B-related diseases in 12 areas in China].
Ma QS; Liang S; Xiao HW; Zhang SX; Zhuang GH; Zou YH; Tan HZ; Liu JC; Zhang YH; Xu AQ; Zhang L; Feng XX; Hu DS; Wang FZ; Cui FQ; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):868-876. PubMed ID: 28738457
[No Abstract] [Full Text] [Related]
8. Direct costs of both inpatient and outpatient care for all type cancers: The evidence from Beijing, China.
Yin X; Xu Y; Man X; Liu L; Jiang Y; Zhao L; Cheng W
Cancer Med; 2019 Jun; 8(6):3250-3260. PubMed ID: 31062522
[TBL] [Abstract][Full Text] [Related]
9. Impact of China's healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study.
Zhu D; Shi X; Nicholas S; Bai Q; He P
BMJ Open; 2019 Aug; 9(8):e029646. PubMed ID: 31401602
[TBL] [Abstract][Full Text] [Related]
10. The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey.
Yang J; Jit M; Leung KS; Zheng YM; Feng LZ; Wang LP; Lau EH; Wu JT; Yu HJ
Infect Dis Poverty; 2015 Oct; 4():44. PubMed ID: 26445412
[TBL] [Abstract][Full Text] [Related]
11. Unbalanced Treatment Costs of Breast Cancer in China: Implications From the Direct Costs of Inpatient and Outpatient Care in Liaoning Province.
Ma Z; Deng G; Meng Z; Ma Y; Wu H
Int J Health Policy Manag; 2022 Sep; 11(9):1735-1743. PubMed ID: 34380200
[TBL] [Abstract][Full Text] [Related]
12. Medication adherence and costs of medical care among patients with Parkinson's disease: an observational study using electronic medical records.
Yi Z; Mao Y; He C; Zhang Y; Zhou J; Feng XL
BMC Public Health; 2024 Apr; 24(1):1202. PubMed ID: 38689223
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off.
Findley LJ; Lees A; Apajasalo M; Pitkänen A; Turunen H
Curr Med Res Opin; 2005 Jul; 21(7):1005-14. PubMed ID: 16004667
[TBL] [Abstract][Full Text] [Related]
14. Real-world assessment of "OFF" episode-related healthcare resource utilization among patients with Parkinson's disease in the United States.
Thach A; Jones E; Pappert E; Pike J; Wright J; Gillespie A
J Med Econ; 2021; 24(1):540-549. PubMed ID: 33819121
[TBL] [Abstract][Full Text] [Related]
15. Estimating the costs of psychiatric hospital services at a public health facility in Nigeria.
Ezenduka C; Ichoku H; Ochonma O
J Ment Health Policy Econ; 2012 Sep; 15(3):139-48. PubMed ID: 23001282
[TBL] [Abstract][Full Text] [Related]
16. Direct Medical Costs of Parkinson's Disease in Southern China: A Cross-Sectional Study Based on Health Insurance Claims Data in Guangzhou City.
Zhang H; Zhou W; Zhang D
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328925
[TBL] [Abstract][Full Text] [Related]
17. Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans.
White RR; Lenhart G; Singhal PK; Insinga RP; Itzler RF; Pellissier JM; Segraves AW
Pharmacoeconomics; 2009; 27(9):781-92. PubMed ID: 19757871
[TBL] [Abstract][Full Text] [Related]
18. The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.
Dodel RC; Singer M; Köhne-Volland R; Szucs T; Rathay B; Scholz E; Oertel WH
Pharmacoeconomics; 1998 Sep; 14(3):299-312. PubMed ID: 10186468
[TBL] [Abstract][Full Text] [Related]
19. Real-world retrospective analysis of patient characteristics, healthcare resource utilization, costs, and treatment patterns among unvaccinated adults with COVID-19 diagnosed in outpatient settings in the United States.
Scott A; Chambers R; Reimbaeva M; Atwell J; Baillon-Plot N; Draica F; Tarallo M
J Med Econ; 2022; 25(1):287-298. PubMed ID: 35114896
[TBL] [Abstract][Full Text] [Related]
20. Establishing a framework for quality of inpatient care for Parkinson's disease: A study on inpatient medication administration.
Yu JRT; Sonneborn C; Hogue O; Ghosh D; Brooks A; Liao J; Fernandez HH; Shaffer S; Sperling SA; Walter BL
Parkinsonism Relat Disord; 2023 Aug; 113():105491. PubMed ID: 37495500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
